Novacyt S.A. (NCYT.L) Director/PDMR Shareholding

Paris, France and Camberley, UK – 12 November 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it has been notified that, on 11 November 2020.

Graham Mullis, Chief Executive of the Company, acquired 60,875 ordinary shares of €1/15 each in the Company at a price of £8.17 per share.  The resultant beneficial shareholding of Mr Mullis is 122,506 ordinary shares representing 0.17% of the Company’s issued share capital.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

 

Graham Mullis, Chief Executive Officer

 

2.

Reason for the Notification

a)

Position/status

See 1(a) – classified as a PDMR of the Company

 

b)

Initial notification/ Amendment

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Novacyt S.A.

b)

LEI

213800BWAC2BF295EG28

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

ordinary shares of €1/15 each

 

Identification code

FR0010397232

b)

Nature of the transaction

Acquisition of Ordinary Shares

 

c)

Price(s) and volume(s)

 

Price

Volume

£8.17

60,875

d)

Aggregated information:

· Aggregated volume

· Price

 

Price

Volume

£8.17

60,875

 

 

e)

Date of the transaction

 

11 November 2020

f)

Place of the transaction

London Stock Exchange, AIM

Contacts

Novacyt SA

Graham Mullis, Chief Executive Officer

Anthony Dyer, Chief Financial Officer

+44 (0)1276 600081


Linking Shareholders and Executives :Share Talk

If anyone reads this article found it useful, helpful? Then please subscribe www.share-talk.com or follow SHARE TALK on our Twitter page for future updates. Terms of Website Use All information is provided on an as-is basis. Where we allow Bloggers to publish articles on our platform please note these are not our opinions or views and we have no affiliation with the companies mentioned
DDDD 750x406 1 - Novacyt S.A. (NCYT.L) Director/PDMR Shareholding
Share via
Copy link
Malcare WordPress Security